Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Unknown status Country / region: China Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20112
20122
20131
20141
20153
20174
20184
201910
202010
20219
20226
20238
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University19
Chinese Academy of Medical Sciences7
Tianjin Medical University Cancer Institute and Hospital3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Peking Union Medical College Hospital2
The First Affiliated Hospital with Nanjing Medical University2
wang shusen2
Abbisko Therapeutics Co, Ltd1
Aiping Shi1
Beijing 302 Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms62
Breast Neoplasms14
Endometrial Neoplasms3
Ovarian Neoplasms3
Mesothelioma, Malignant2
Neoplasms2
Adenocarcinoma of Lung1
Brain Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.